Sycamore Partners has completed its acquisition of Walgreens Boots Alliance, Inc. The transaction sees Walgreens, The Boots Group, Shields Health Solutions, CareCentrix, and VillageMD continuing as separate standalone companies. Sycamore has partnered with Stefano Pessina and his family, who have reinvested their interests in Walgreens Boots Alliance, indicating ongoing support for the company's future. Following the acquisition, Walgreens Boots Alliance's common stock will no longer be traded on the Nasdaq. WBA shareholders will receive cash consideration of $11.45 per share and the potential for an additional cash payment based on future monetization of WBA's interests in VillageMD.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Walgreens Boots Alliance Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250827891313) on August 28, 2025, and is solely responsible for the information contained therein.